Mast cell leukemia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Mast cell leukemia | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fatigue, weight loss, fever, skin lesions, abdominal pain |
| Complications | Anemia, thrombocytopenia, hepatosplenomegaly, gastrointestinal bleeding |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations in mast cells |
| Risks | Unknown |
| Diagnosis | Bone marrow biopsy, blood test |
| Differential diagnosis | Systemic mastocytosis, acute myeloid leukemia |
| Prevention | N/A |
| Treatment | Chemotherapy, tyrosine kinase inhibitors, stem cell transplant |
| Medication | N/A |
| Prognosis | Poor |
| Frequency | Very rare |
| Deaths | N/A |
Mast cell leukemia is a rare and aggressive subtype of systemic mastocytosis characterized by the proliferation of mast cells in the bone marrow and other organs. It is classified as a myeloproliferative neoplasm and is associated with a poor prognosis.
Signs and symptoms[edit]
Patients with mast cell leukemia often present with symptoms related to the infiltration of mast cells into various organs. These can include fatigue, weight loss, fever, and abdominal pain. In addition, the release of histamine and other mediators from mast cells can cause flushing, itching, diarrhea, and anaphylactic reactions.
Diagnosis[edit]
The diagnosis of mast cell leukemia is based on the presence of mast cells in the bone marrow and other tissues, as well as the presence of certain mutations in the KIT gene. Other diagnostic tests can include blood tests, bone marrow examination, and genetic testing.
Treatment[edit]
Treatment for mast cell leukemia is typically aggressive and can include chemotherapy, stem cell transplantation, and targeted therapies such as tyrosine kinase inhibitors.
Prognosis[edit]
The prognosis for mast cell leukemia is generally poor, with a median survival time of less than a year. However, some patients may respond well to treatment and achieve a longer survival time.
See also[edit]
References[edit]
<references />
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
